Pre-ASH Crash Course
BioPharm Insight is your definitive guide to the global biopharma community, combining an online business intelligence system of comprehensive market analytics and key industry contacts with an independent investigative journalism news service to give you an information edge.
Be an Active Participant in Your Industry
Featuring an intuitive user interface, precise custom searches, real-time alerts, unrivaled personal support and exclusive Active Intel technology linking data with intelligence, BioPharm Insight is an online system providing clients with robust market analytics and comprehensive database of:
- 500,000 management and R&D contacts
- 7,500 biopharma companies with full pipeline data
- 250,000 investigational and approved drug profiles
- 15,000 M&A and licensing deals
- 7,000 extended sales forecasts
- Epidemiology profiles for hundreds of indications
The Story Behind the Data
BioPharm Insight, part of the Financial Times Group, is also an acclaimed independent journalist team with a proven track record of breaking forward-looking and competitive business intelligence 6-12 months ahead of mainstream press. Based in our news bureaus in New York, London, Washington DC, Hong Kong, Shanghai and Tokyo, reporters conduct in-depth interviews with subject matter experts to ensure subscribers take action on reliable global intelligence.